Vera Therapeutics completed full enrolment in its pivotal trial of atacicept in IgA nephropathy and Minovia Therapeutics received …
Vera Therapeutics completed full enrolment in its pivotal trial of atacicept in IgA nephropathy and Minovia Therapeutics received …
In a shareholder letter released on 1 April 2025, MAIA Biotechnology revealed plans to advance telomere‐targeted therapies in …
Novartis receives a landmark approval for iptacopan (Fabhalta®), offering new hope for patients with a rare kidney disorder.
Precision BioSciences receives IND clearance to launch US-based trial of PBGENE-HBV, a meganuclease gene-editing candidate for a functional …
Long-term clinical data from Roche strengthen the case for disease-modifying therapies in spinal muscular atrophy and Duchenne muscular …
March 2025 is marked by significant deal-making, promising clinical trial results, and innovations across small molecules, biologics, and …
India’s Sun Pharmaceutical Industries strengthens its immuno-oncology capabilities with acquisition of U.S.-based Checkpoint Therapeutics.
The biopharma sector sees soaring merger and acquisition activity in March 2025, with major deals advancing innovation in …
Long-term data demonstrate that EBGLYSS offers durable skin improvement and symptom relief, reinforcing its role as a first-line …
Investments in next-generation manufacturing facilities are unlocking scale, speed, and quality for cell and gene therapies, propelling North …
Already a subscriber? Log in